In this perspective article we summarize relevant data pinpointing the contribution of galectins to the pathogenesis of RA (Figure 1) and report new clinical observations, highlighting the differential regulation of Gal-1 and Gal-3 at the systemic level in RA patients and their association with disease activity (Figure 2). This evidence concerns the gene LGALS1 and rheumatoid arthritis.